Cytoprotective Effects of Human Platelet Lysate during the Xeno-Free Culture of Human Donor Corneas.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
02 Feb 2023
Historique:
received: 28 10 2022
revised: 18 01 2023
accepted: 25 01 2023
entrez: 11 2 2023
pubmed: 12 2 2023
medline: 15 2 2023
Statut: epublish

Résumé

We evaluated the suitability of 2% human platelet lysate medium (2%HPL) as a replacement for 2% fetal bovine serum medium (2%FBS) for the xeno-free organ culture of human donor corneas. A total of 32 corneas from 16 human donors were cultured in 2%FBS for 3 days (TP1), then evaluated using phase contrast microscopy (endothelial cell density (ECD) and cell morphology). Following an additional 25-day culture period (TP2) in either 2%FBS or 2%HPL, the pairs were again compared using microscopy; then stroma and Descemet membrane/endothelium (DmE) were processed for next generation sequencing (NGS). At TP2 the ECD was higher in the 2%HPL group (2179 ± 288 cells/mm

Identifiants

pubmed: 36769200
pii: ijms24032882
doi: 10.3390/ijms24032882
pmc: PMC9917909
pii:
doi:

Substances chimiques

Culture Media 0
FABP5 protein, human 0
Fatty Acid-Binding Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Regen Med. 2016 Sep;11(6):601-15
pubmed: 27498943
Elife. 2020 Feb 25;9:
pubmed: 32096760
Arch Ophthalmol. 2000 Jun;118(6):757-60
pubmed: 10865310
Int Rev Cell Mol Biol. 2020;355:1-52
pubmed: 32859368
Invest Ophthalmol Vis Sci. 2020 May 11;61(5):62
pubmed: 32462202
Molecules. 2020 Aug 28;25(17):
pubmed: 32872164
Eye Contact Lens. 2018 Mar;44(2):69-76
pubmed: 28328727
J Environ Pathol Toxicol Oncol. 2021;40(3):87-94
pubmed: 34587407
Lancet. 1997 Apr 5;349(9057):990-3
pubmed: 9100626
Glycobiology. 2022 Jun 13;32(7):556-579
pubmed: 35312770
Arch Biochem Biophys. 2022 Aug 15;725:109283
pubmed: 35577071
Int J Immunopharmacol. 1997 May;19(5):255-62
pubmed: 9439764
Mol Cell Proteomics. 2014 Feb;13(2):397-406
pubmed: 24309898
Am J Ophthalmol. 2017 Oct;182:62-71
pubmed: 28739420
Acta Ophthalmol. 2018 Sep;96(6):e718-e726
pubmed: 29520992
Hepatology. 2017 Jun;65(6):1948-1962
pubmed: 28073159
Acta Ophthalmol. 2016 Feb;94(1):70-5
pubmed: 26146765
Exp Eye Res. 2008 Sep;87(3):214-25
pubmed: 18582462
PLoS One. 2010 Mar 29;5(3):e9911
pubmed: 20360971
J Adv Res. 2022 Sep;40:197-206
pubmed: 36100327
JAMA Ophthalmol. 2016 Feb;134(2):167-73
pubmed: 26633035
Cochrane Database Syst Rev. 2018 Jun 25;6:CD012097
pubmed: 29940078
Front Immunol. 2021 Jun 21;12:676702
pubmed: 34276664
PLoS One. 2012;7(10):e47187
pubmed: 23056608
Cell Mol Life Sci. 2020 Jun;77(12):2367-2386
pubmed: 31471680
Cells. 2021 Apr 30;10(5):
pubmed: 33946345
Cell Transplant. 2015;24(2):287-304
pubmed: 24268186
FEBS Lett. 1998 Sep 4;434(3):300-4
pubmed: 9742942
Sci Rep. 2021 Aug 11;11(1):16323
pubmed: 34381080
N Engl J Med. 2000 Jul 13;343(2):86-93
pubmed: 10891515
Nucleic Acids Res. 2010 May;38(9):2931-43
pubmed: 20100802
Annu Rev Pharmacol Toxicol. 2010;50:323-54
pubmed: 20055707
PLoS One. 2015 Jul 23;10(7):e0133173
pubmed: 26203910
Exp Eye Res. 2005 Jan;80(1):1-8
pubmed: 15652520
Doc Ophthalmol. 1983 Dec 15;56(1-2):147-53
pubmed: 6363024
Genome Biol. 2014;15(12):550
pubmed: 25516281
Cytotherapy. 2014 Feb;16(2):170-80
pubmed: 24438898
Am J Pathol. 2014 May;184(5):1429-45
pubmed: 24650561
Cornea. 2003 Jul;22(5):457-64
pubmed: 12827052
Sci Rep. 2017 Mar 28;7:45396
pubmed: 28349952
Biomed Res Int. 2021 Apr 10;2021:5541780
pubmed: 33937393
Ocul Surf. 2021 Jul;21:279-298
pubmed: 33865984
Stem Cells. 2006 Oct;24(10):2232-43
pubmed: 16763199
Int Immunol. 2011 Jul;23(7):415-20
pubmed: 21632975
Blood. 1997 Feb 1;89(3):776-9
pubmed: 9028307
Int J Biol Macromol. 2021 Aug 31;185:264-276
pubmed: 34119551
Invest Ophthalmol Vis Sci. 2015 Aug;56(9):5503-11
pubmed: 26284556
Cells. 2022 Jan 05;11(1):
pubmed: 35011740
Cornea. 2019 Apr;38(4):480-484
pubmed: 30681513
Nat Biotechnol. 2020 Mar;38(3):276-278
pubmed: 32055031
Graefes Arch Clin Exp Ophthalmol. 2010 Jan;248(1):117-26
pubmed: 19774353
Mol Immunol. 2020 Oct;126:31-39
pubmed: 32745796
Cancer Immunol Immunother. 2000 Jun;49(3):152-6
pubmed: 10881694
Sci Rep. 2020 Jul 6;10(1):11086
pubmed: 32632151
Int J Mol Sci. 2018 May 09;19(5):
pubmed: 29747422
Mol Vis. 2007 Oct 16;13:1934-41
pubmed: 17982417
Biochem J. 1996 Aug 15;318 ( Pt 1):1-14
pubmed: 8761444
Immunotherapy. 2011 Jun;3(6):757-70
pubmed: 21668313
Am J Ophthalmol. 2018 Apr;188:91-98
pubmed: 29410297
J Exp Med. 2001 Sep 17;194(6):855-61
pubmed: 11561000
Cornea. 2016 Sep;35(9):1216-21
pubmed: 27429079
J Cell Mol Med. 2021 Oct;25(20):9647-9659
pubmed: 34486211
Acta Ophthalmol. 2017 Mar;95(2):205-210
pubmed: 27233584
Int J Mol Sci. 2023 Jan 11;24(2):
pubmed: 36674976
Sci Rep. 2020 Oct 15;10(1):17359
pubmed: 33060618
Ophthalmology. 2021 Apr;128(4):504-514
pubmed: 32898516
Biotechnol J. 2018 Jan;13(1):
pubmed: 28873283
J Cancer Res Clin Oncol. 2010 Feb;136(2):309-21
pubmed: 19727817
Database (Oxford). 2015 Feb 27;2015:
pubmed: 25725062
Commun Biol. 2021 Mar 1;4(1):266
pubmed: 33649486
Bioengineering (Basel). 2020 Jul 06;7(3):
pubmed: 32640721
Int Ophthalmol. 2008 Jun;28(3):155-63
pubmed: 17505780
Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5038-45
pubmed: 17962455
J Clin Invest. 2001 Sep;108(5):689-701
pubmed: 11544274
Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10538-42
pubmed: 20498044
Cancer Res. 2010 Dec 15;70(24):10474-84
pubmed: 21159657
Cell Mol Life Sci. 2009 Aug;66(16):2623-42
pubmed: 19381436
Invest Ophthalmol Vis Sci. 2019 Aug 1;60(10):3636-3643
pubmed: 31469403
Invest Ophthalmol Vis Sci. 2004 Jan;45(1):245-52
pubmed: 14691180
Cancers (Basel). 2021 Mar 16;13(6):
pubmed: 33809543
Invest Ophthalmol Vis Sci. 2013 Aug 09;54(8):5400-7
pubmed: 23821192
Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3340-3354
pubmed: 30025076
Arch Ophthalmol. 1995 Jun;113(6):805-9
pubmed: 7786224
Exp Eye Res. 2021 Jul;208:108613
pubmed: 33984343
J Cell Mol Med. 2014 Apr;18(4):624-34
pubmed: 24444305
BMC Ophthalmol. 2017 Nov 17;17(1):204
pubmed: 29149876
Sci Rep. 2017 Jul 24;7(1):6303
pubmed: 28740178
Hum Gene Ther. 2002 Sep 1;13(13):1605-10
pubmed: 12228015
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Clin Exp Ophthalmol. 2018 Dec;46(9):1017-1027
pubmed: 29855131
Dev Dyn. 2018 Nov;247(11):1186-1198
pubmed: 30295986
Nat Biotechnol. 2017 Apr 11;35(4):316-319
pubmed: 28398311
Transfus Med Hemother. 2011;38(2):143-147
pubmed: 21566714
Front Endocrinol (Lausanne). 2020 Mar 03;11:24
pubmed: 32194500
N Engl J Med. 2010 Jul 8;363(2):147-55
pubmed: 20573916
J Clin Cell Immunol. 2013 Nov 20;2013(Suppl 9):
pubmed: 24634796
Biochem Biophys Res Commun. 2019 Oct 1;517(4):729-734
pubmed: 31387745
J Tissue Eng Regen Med. 2018 Feb;12(2):557-564
pubmed: 28941176
Mol Vis. 2008 Apr 21;14:762-73
pubmed: 18432318
Invest Ophthalmol Vis Sci. 2012 Mar 09;53(3):1285-95
pubmed: 22323486
PLoS One. 2013 Jun 18;8(6):e66468
pubmed: 23824597
Cancer Res. 2003 Oct 15;63(20):6651-7
pubmed: 14583458
Am J Transplant. 2019 Jun;19(6):1641-1651
pubmed: 30589181
Exp Dermatol. 2005 Sep;14(9):709-18
pubmed: 16098131
J Cell Mol Med. 2018 Jun;22(6):3119-3132
pubmed: 29536619
Radiat Res. 2018 Feb;189(2):177-186
pubmed: 29215326
Nucleic Acids Res. 2020 Jan 8;48(D1):D650-D658
pubmed: 31552413
Blood. 1994 Nov 15;84(10):3483-93
pubmed: 7949102
Eur J Hum Genet. 2017 May;25(5):582-590
pubmed: 28145428
Adv Healthc Mater. 2019 May;8(9):e1801378
pubmed: 30901162
Dev Ophthalmol. 2009;43:47-62
pubmed: 19494636
Blood. 2007 Nov 15;110(10):3691-4
pubmed: 17684157
FEBS J. 2005 Nov;272(22):5821-31
pubmed: 16279946
Sci Signal. 2009 Jul 21;2(80):ra35
pubmed: 19622832
J Cell Physiol. 2005 Nov;205(2):228-36
pubmed: 15887229
Nat Methods. 2017 Apr;14(4):417-419
pubmed: 28263959
Neurobiol Dis. 2009 Jan;33(1):104-10
pubmed: 18977442
Pharmacol Ther. 2019 Sep;201:181-201
pubmed: 31158394
Graefes Arch Clin Exp Ophthalmol. 2021 Sep;259(9):2731-2741
pubmed: 33977320
Cell Transplant. 2016;25(6):1159-76
pubmed: 26337789
Acta Ophthalmol. 2021 Jun;99(4):e615-e617
pubmed: 32767497
Invest Ophthalmol Vis Sci. 2014 Jul 01;55(8):4691-9
pubmed: 24985478
Stem Cell Res Ther. 2022 Jun 21;13(1):268
pubmed: 35729640
Trends Biochem Sci. 2020 Jan;45(1):6-12
pubmed: 31704057
J Med Genet. 2006 Aug;43(8):699-704
pubmed: 16505158

Auteurs

Delia Talpan (D)

Department of Ophthalmology, RWTH Aachen University, 52074 Aachen, Germany.

Sabine Salla (S)

Department of Ophthalmology, RWTH Aachen University, 52074 Aachen, Germany.
Cornea Bank Aachen, RWTH Aachen University, 52074 Aachen, Germany.

Linus Meusel (L)

Department of Ophthalmology, RWTH Aachen University, 52074 Aachen, Germany.
Cornea Bank Aachen, RWTH Aachen University, 52074 Aachen, Germany.

Peter Walter (P)

Department of Ophthalmology, RWTH Aachen University, 52074 Aachen, Germany.
Cornea Bank Aachen, RWTH Aachen University, 52074 Aachen, Germany.

Chao-Chung Kuo (CC)

Genomics Facility, Interdisciplinary Center for Clinical Research (IZKF), RWTH Aachen University, 52074 Aachen, Germany.

Julia Franzen (J)

Genomics Facility, Interdisciplinary Center for Clinical Research (IZKF), RWTH Aachen University, 52074 Aachen, Germany.

Matthias Fuest (M)

Department of Ophthalmology, RWTH Aachen University, 52074 Aachen, Germany.
Cornea Bank Aachen, RWTH Aachen University, 52074 Aachen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH